BIOJECT MEDICAL TECHNOLOGIES INC 4
4 · BIOJECT MEDICAL TECHNOLOGIES INC · Filed Dec 8, 2009
Insider Transaction Report
Form 4
FARRELL CHRISTINE
VP of Finance
Transactions
- Exercise/Conversion
BJCT Common Stock
2009-12-07+5,000→ 201,443 total - Purchase
Restricted Stock Unit
2009-12-07−5,000→ 188,796 totalFrom: 2009-12-07→ BJCT Common Stock (5,000 underlying)
Holdings
- 73,687(indirect: By 401(k))
BJCT Common Stock
Footnotes (4)
- [F1]Vesting of Unconditional Restricted Stock Unit awarded December 7, 2006.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of BJCT Common Stock.
- [F3]No expiration date.
- [F4]Includes Series F Preferred Stock 10,100, Warrant (right-to-buy) 1,000, Option (right-to-buy) 64,696 Restricted Stock Unit 113,000.